Corbevax (English Wikipedia)

Hotez PJ, Bottazzi ME (30 December 2021). "A COVID Vaccine for All". Scientific American. Archived from the original on 30 December 2021. Retrieved 2 January 2022.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Hotez PJ, Bottazzi ME (January 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55–64. doi:10.1146/annurev-med-042420-113212. PMID 34637324. S2CID 238747462.

theguardian.com (Global: 12^th place; English: 11^th place)

Salam E (15 January 2022). "Texas scientists' new Covid-19 vaccine is cheaper, easier to make and patent-free". the Guardian. Retrieved 13 August 2022.

thehindu.com (Global: 52^nd place; English: 35^th place)

"Coronavirus | Biological E gets nod to start Phase III trials of COVID-19 vaccine". The Hindu. 24 April 2021.

theprint.in (Global: 987^th place; English: 560^th place)

Basu N (25 April 2021). "US assures export of raw materials to India for Covid vaccines as Doval speaks to Sullivan". ThePrint.

titosvodka.com (Global: low place; English: low place)

"Supporting COVID-19 Research". Tito's Vodka. 13 May 2020. Retrieved 29 January 2022.

vice.com (Global: 175^th place; English: 137^th place)

"Open-Source Vaccines Got More Funding From Tito's Vodka Than the Government". Vice.com. 11 January 2022. Retrieved 25 January 2022.

washingtonpost.com (Global: 34^th place; English: 27^th place)

"A new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothing in return". The Washington Post. 30 December 2021. Archived from the original on 1 January 2022.

web.archive.org (Global: 1^st place; English: 1^st place)

"A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers". ctri.nic.in. Clinical Trials Registry India. 13 January 2021. CTRI/2020/11/029032. Archived from the original on 12 November 2020.
"CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate". cepi.net. CEPI. 29 December 2020. Archived from the original on 29 December 2020. Retrieved 5 March 2021.
"A Prospective, multicentre, Phase II Seamlessly Followed by Phase III Clinical Study to Evaluate the Immunogenicity and Safety of Biological E's CORBEVAX Vaccine for Protection Against COVID-19 Disease When Administered to COVID-19-Negative Adult Subjects". ctri.nic.in. Clinical Trials Registry India. 5 June 2021. CTRI/2021/06/034014. Archived from the original on 5 June 2021.
Hotez PJ, Bottazzi ME (30 December 2021). "A COVID Vaccine for All". Scientific American. Archived from the original on 30 December 2021. Retrieved 2 January 2022.

Corbevax (English Wikipedia)

archive.today (Global: 14th place; English: 14th place)

bbc.com (Global: 20th place; English: 30th place)

bcm.edu (Global: low place; English: low place)

cepi.net (Global: low place; English: low place)

ctri.nic.in (Global: low place; English: low place)

deccanherald.com (Global: 516th place; English: 291st place)

doi.org (Global: 2nd place; English: 2nd place)

dynavax.com (Global: low place; English: low place)

investors.dynavax.com

harvard.edu (Global: 18th place; English: 17th place)

hms.harvard.edu

hindustantimes.com (Global: 71st place; English: 52nd place)

indianexpress.com (Global: 60th place; English: 43rd place)

indiatimes.com (Global: 17th place; English: 15th place)

timesofindia.indiatimes.com

livemint.com (Global: 390th place; English: 227th place)

ndtv.com (Global: 138th place; English: 95th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

npr.org (Global: 92nd place; English: 72nd place)

scientificamerican.com (Global: 896th place; English: 674th place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

theguardian.com (Global: 12th place; English: 11th place)

thehindu.com (Global: 52nd place; English: 35th place)

theprint.in (Global: 987th place; English: 560th place)

titosvodka.com (Global: low place; English: low place)

vice.com (Global: 175th place; English: 137th place)

washingtonpost.com (Global: 34th place; English: 27th place)

web.archive.org (Global: 1st place; English: 1st place)

archive.today (Global: 14^th place; English: 14^th place)

bbc.com (Global: 20^th place; English: 30^th place)

deccanherald.com (Global: 516^th place; English: 291^st place)

doi.org (Global: 2^nd place; English: 2^nd place)

harvard.edu (Global: 18^th place; English: 17^th place)

hindustantimes.com (Global: 71^st place; English: 52^nd place)

indianexpress.com (Global: 60^th place; English: 43^rd place)

indiatimes.com (Global: 17^th place; English: 15^th place)

livemint.com (Global: 390^th place; English: 227^th place)

ndtv.com (Global: 138^th place; English: 95^th place)

nih.gov (Global: 4^th place; English: 4^th place)

npr.org (Global: 92^nd place; English: 72^nd place)

scientificamerican.com (Global: 896^th place; English: 674^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

theguardian.com (Global: 12^th place; English: 11^th place)

thehindu.com (Global: 52^nd place; English: 35^th place)

theprint.in (Global: 987^th place; English: 560^th place)

vice.com (Global: 175^th place; English: 137^th place)

washingtonpost.com (Global: 34^th place; English: 27^th place)

web.archive.org (Global: 1^st place; English: 1^st place)